BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

450 related articles for article (PubMed ID: 26292924)

  • 1. Large-scale RNA-Seq Transcriptome Analysis of 4043 Cancers and 548 Normal Tissue Controls across 12 TCGA Cancer Types.
    Peng L; Bian XW; Li DK; Xu C; Wang GM; Xia QY; Xiong Q
    Sci Rep; 2015 Aug; 5():13413. PubMed ID: 26292924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RNA-Seq accurately identifies cancer biomarker signatures to distinguish tissue of origin.
    Wei IH; Shi Y; Jiang H; Kumar-Sinha C; Chinnaiyan AM
    Neoplasia; 2014 Nov; 16(11):918-27. PubMed ID: 25425966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comprehensive genomic pan-cancer classification using The Cancer Genome Atlas gene expression data.
    Li Y; Kang K; Krahn JM; Croutwater N; Lee K; Umbach DM; Li L
    BMC Genomics; 2017 Jul; 18(1):508. PubMed ID: 28673244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequential analysis of transcript expression patterns improves survival prediction in multiple cancers.
    Mandel J; Avula R; Prochownik EV
    BMC Cancer; 2020 Apr; 20(1):297. PubMed ID: 32264880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dysregulated transcription across diverse cancer types reveals the importance of RNA-binding protein in carcinogenesis.
    Wang J; Liu Q; Shyr Y
    BMC Genomics; 2015; 16 Suppl 7(Suppl 7):S5. PubMed ID: 26100984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptional Profiles from Paired Normal Samples Offer Complementary Information on Cancer Patient Survival--Evidence from TCGA Pan-Cancer Data.
    Huang X; Stern DF; Zhao H
    Sci Rep; 2016 Feb; 6():20567. PubMed ID: 26837275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-cancer profiling of molecular alterations within the human autophagy interaction network.
    Lebovitz CB; Robertson AG; Goya R; Jones SJ; Morin RD; Marra MA; Gorski SM
    Autophagy; 2015; 11(9):1668-87. PubMed ID: 26208877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The expression signature of cancer-associated KRAB-ZNF factors identified in TCGA pan-cancer transcriptomic data.
    Machnik M; Cylwa R; Kiełczewski K; Biecek P; Liloglou T; Mackiewicz A; Oleksiewicz U
    Mol Oncol; 2019 Apr; 13(4):701-724. PubMed ID: 30444046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct signatures of codon and codon pair usage in 32 primary tumor types in the novel database CancerCoCoPUTs for cancer-specific codon usage.
    Meyer D; Kames J; Bar H; Komar AA; Alexaki A; Ibla J; Hunt RC; Santana-Quintero LV; Golikov A; DiCuccio M; Kimchi-Sarfaty C
    Genome Med; 2021 Jul; 13(1):122. PubMed ID: 34321100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leveraging global gene expression patterns to predict expression of unmeasured genes.
    Rudd J; Zelaya RA; Demidenko E; Goode EL; Greene CS; Doherty JA
    BMC Genomics; 2015 Dec; 16():1065. PubMed ID: 26666289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular Correlates of Metastasis by Systematic Pan-Cancer Analysis Across The Cancer Genome Atlas.
    Chen F; Zhang Y; Varambally S; Creighton CJ
    Mol Cancer Res; 2019 Feb; 17(2):476-487. PubMed ID: 30401717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integration of microRNA signatures of distinct mammary epithelial cell types with their gene expression and epigenetic portraits.
    Pal B; Chen Y; Bert A; Hu Y; Sheridan JM; Beck T; Shi W; Satterley K; Jamieson P; Goodall GJ; Lindeman GJ; Smyth GK; Visvader JE
    Breast Cancer Res; 2015 Jun; 17(1):85. PubMed ID: 26080807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative or qualitative transcriptional diagnostic signatures? A case study for colorectal cancer.
    Guan Q; Yan H; Chen Y; Zheng B; Cai H; He J; Song K; Guo Y; Ao L; Liu H; Zhao W; Wang X; Guo Z
    BMC Genomics; 2018 Jan; 19(1):99. PubMed ID: 29378509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiogenic gene signature in human pancreatic cancer correlates with TGF-beta and inflammatory transcriptomes.
    Craven KE; Gore J; Wilson JL; Korc M
    Oncotarget; 2016 Jan; 7(1):323-41. PubMed ID: 26586478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alternative preprocessing of RNA-Sequencing data in The Cancer Genome Atlas leads to improved analysis results.
    Rahman M; Jackson LK; Johnson WE; Li DY; Bild AH; Piccolo SR
    Bioinformatics; 2015 Nov; 31(22):3666-72. PubMed ID: 26209429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic stromal gene signatures in breast cancer.
    Winslow S; Leandersson K; Edsjö A; Larsson C
    Breast Cancer Res; 2015 Feb; 17(1):23. PubMed ID: 25848820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meta-analysis of prostate cancer gene expression data identifies a novel discriminatory signature enriched for glycosylating enzymes.
    Barfeld SJ; East P; Zuber V; Mills IG
    BMC Med Genomics; 2014 Dec; 7():513. PubMed ID: 25551447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Whole-Transcriptome profiling of formalin-fixed, paraffin-embedded renal cell carcinoma by RNA-seq.
    Li P; Conley A; Zhang H; Kim HL
    BMC Genomics; 2014 Dec; 15(1):1087. PubMed ID: 25495041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of Gene-Expression Signatures and Protein Markers for Breast Cancer Grading and Staging.
    Yao F; Zhang C; Du W; Liu C; Xu Y
    PLoS One; 2015; 10(9):e0138213. PubMed ID: 26375396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Network-based stratification analysis of 13 major cancer types using mutations in panels of cancer genes.
    Zhong X; Yang H; Zhao S; Shyr Y; Li B
    BMC Genomics; 2015; 16 Suppl 7(Suppl 7):S7. PubMed ID: 26099277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.